[{"Assets_0_Q3_USD":17127062.0,"CommonStockSharesOutstanding_0_Q3_shares":24659052.0,"EarningsPerShareBasic_1_Q3_USD":-0.22,"EarningsPerShareBasic_3_Q3_USD":-1.36,"EarningsPerShareDiluted_1_Q3_USD":-0.22,"EarningsPerShareDiluted_3_Q3_USD":-1.53,"NetIncomeLoss_1_Q3_USD":-5326918.0,"NetIncomeLoss_3_Q3_USD":-32470516.0,"StockholdersEquity_0_Q3_USD":-28941534.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":24442056.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":23813910.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":23788046.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":24442056.0,"Ticker":"OTLK","CIK":"1649989","name":"ONCOBIOLOGICS, INC.","OfficialName":"Outlook Therapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"403697299.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170814"}]